Heart failure

Heart failure in obesity: insights into proteomics in patients treated with or without bariatric surgery

  • CNDRF collaboration. Global trends in body mass index, underweight, overweight and obesity from 1975 to 2016: a pooled analysis of 2,416 population-based measurement studies involving 128.9 million children , teenagers and adults. Lancet. 2017;390:2627–42.

    Article

    Google Scholar

  • Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in the prevalence of obesity and severe obesity among American youth and adults by sex and age, 2007-2008 to 2015-2016. JAMA. 2018;319:1723–5.

    PubMed
    PubMed Center
    Article

    Google Scholar

  • Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and risk of heart failure. N Engl J Med. 2002;347:305–13.

    PubMed
    Article

    Google Scholar

  • Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, et al. Body mass index, abdominal adiposity, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Traffic. 2016;133:639–49.

    PubMed
    Article

    Google Scholar

  • By Maria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356:2176–83.

    CASE
    PubMed
    Article

    Google Scholar

  • Sjostrom L. Review of the main results of the Swedish trial in obese subjects (SOS) – a prospective controlled intervention study of bariatric surgery. J Med Intern. 2013;273:219–34.

    CASE
    PubMed
    Article

    Google Scholar

  • Jacobs L, Efremov L, Ferreira JP, Thijs L, Yang WY, Zhang ZY, et al. Risk of incident heart failure: a subject-level meta-analysis from the OMics Heart Aging (HOMAGE) Study. J Am Heart Assoc. 2017;6.

  • Sahle BW, Owen AJ, Chin KL, Reid CM. Models for predicting the risk of incident heart failure: a systematic review of methodology and model performance. Failed Map J. 2017;23:680–7.

    PubMed
    Article

    Google Scholar

  • Tyers M, Mann M. From genomics to proteomics. Nature. 2003;422:193–7.

    CASE
    PubMed
    Article

    Google Scholar

  • Singla P, Bardoloi A, Parkash AA. Metabolic effects of obesity: a review. World J Diabetes. 2010;1:76–88.

    PubMed
    PubMed Center
    Article

    Google Scholar

  • Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, assessment, and effect of weight loss: an update of the American Heart Association’s 1997 scientific statement on obesity and heart disease from the Obesity Committee of the Council on the nutrition, physical activity and metabolism. Traffic. 2006;113:898–918.

    PubMed
    Article

    Google Scholar

  • Sjostrom L, Larsson B, Backman L, Bengtsson C, Bouchard C, Dahlgren S, et al. Swedish Obese Subjects (SOS). Recruitment for an interventional study and a selective description of the obese state. Int J Obesity. 1992;16:465–79.

    CASE

    Google Scholar

  • Essebag V, Genest Jr., Suissa S, Pilote L. The nested case-control study in cardiology. Am Heart J. 2003;146:581–90.

    PubMed
    Article

    Google Scholar

  • Hsieh FY, Bloch DA, Larsen MD. A simple method of calculating sample size for linear and logistic regression. StatMed. 1998;17:1623–34.

    CASE
    PubMed
    Article

    Google Scholar

  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Stat Soc. 1995;57:289–300.

    Google Scholar

  • Kamburov A, Stelzl U, Lehrach H, Herwig R. The ConsensusPathDB Interaction Database: 2013 Update. Nucleic Acids Res. 2013;41:D793–800.

    CASE
    PubMed
    Article

    Google Scholar

  • Greenland S. Interaction tests in epidemiological studies: a review and power study. StatMed. 1983;2:243–51.

    CASE
    PubMed
    Article

    Google Scholar

  • Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyzes in randomized trials: risks of subgroup-specific analyses; the power and sample size for the interaction test. J Clin Epidemiol. 2004;57:229–36.

    PubMed
    Article

    Google Scholar

  • Schwenk RW, Vogel H, Schurmann A. Genetic and epigenetic control of metabolic health. Mol Metab. 2013;2:337–47.

    CASE
    PubMed
    PubMed Center
    Article

    Google Scholar

  • Xu S, Lind L, Zhao L, Lindahl B, Venge P. Plasma prolylcarboxypeptidase (angiotensinase C) is increased in obesity and diabetes mellitus and linked to cardiovascular dysfunction. Clin Chem. 2012;58:1110–5.

    CASE
    PubMed
    Article

    Google Scholar

  • Micheau O Regulation of ligand signaling inducing TNF-related apoptosis by glycosylation. Int J Mol Sci. 2018;19.

  • Hanasaki K, Varki A, Stamenkovic I, Bevilacqua MP. Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha 2,6-sialylation of CD22 adhesion molecules and ligands. J Biol Chem. 1994;269:10637–43.

    CASE
    PubMed
    Article

    Google Scholar

  • Kosmala W, Plaksej R, Przewlocka-Kosmala M, Kuliczkowska-Plaksej J, Bednarek-Tupikowska G, Mazurek W. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship with cardiac function. Int J Obes. 2008;32:763–71.

    CASE
    Article

    Google Scholar

  • Cynis H, Hoffmann T, Friedrich D, Kehlen A, Gans K, Kleinschmidt M, et al. The glutaminyl cyclase isoenzyme is an important regulator of monocyte infiltration under inflammatory conditions. EMBO Mol Med. 2011;3:545–58.

    CASE
    PubMed
    PubMed Center
    Article

    Google Scholar

  • Zhu R, Liu C, Tang H, Zeng Q, Wang X, Zhu Z, et al. Serum galectin-9 levels are associated with coronary heart disease in Chinese individuals. Inflamm. Mediators 2015;2015:457167.

    PubMed
    PubMed Center

    Google Scholar

  • Suzuki K. The multifunctional serpin, protein C inhibitor: beyond thrombosis and hemostasis. J Thromb Haemost. 2008;6:2017–26.

    CASE
    PubMed
    Article

    Google Scholar

  • Ruge T, Carlsson AC, Ingelsson E, Riserus U, Sundstrom J, Larsson A, et al. Circulating endostatin and the incidence of heart failure. Scand Cardiovascular J. 2018;52:244–9.

    CASE
    PubMed
    Article

    Google Scholar

  • Stenemo M, Nowak C, Byberg L, Sundstrom J, Giedraitis V, Lind L, et al. Circulating proteins as predictors of incident heart failure in the elderly. Eur J Heart failure. 2018;20:55–62.

    CASE
    PubMed
    Article

    Google Scholar

  • Rip J, Nierman MC, Ross CJ, Jukema JW, Hayden MR, Kastelein JJ, et al. Lipoprotein lipase S447X: a natural gain-of-function mutation. Arterioscler Thromb Vasc Biol. 2006;26:1236–45.

    CASE
    PubMed
    Article

    Google Scholar

  • Bjorkbacka H, ​​Yao Mattisson I, Wigren M, Melander O, Fredrikson GN, Bengtsson E, et al. Plasma stem cell factor levels are associated with the risk of cardiovascular disease and death. J Med Intern. 2017;282:508–21.

    CASE
    PubMed
    Article

    Google Scholar

  • Yang H, Geiger M. Cell penetrating SERPINA5 (protein C inhibitor, PCI): more questions than answers. Semin Cell Dev Biol. 2017;62:187–93.

    CASE
    PubMed
    Article

    Google Scholar

  • Carroll VA, Griffiths MR, Geiger M, Merlo C, Furlan M, Lammle B, et al. Plasma protein C inhibitor is elevated in myocardial infarction survivors. Arterioscler Thromb Vasc Biol. 1997;17:114–8.

    CASE
    PubMed
    Article

    Google Scholar

  • Wang XQ, Liu ZH, Xue L, Lu L, Gao J, Shen Y, et al. C1q/TNF-related protein 1 links macrophage lipid metabolism to inflammation and atherosclerosis. Atherosclerosis. 2016;250:38–45.

    CASE
    PubMed
    Article

    Google Scholar

  • Wang H, Wang R, Du D, Li F, Li Y. Serum levels of C1q/TNF-related protein-1 (CTRP-1) are strongly associated with coronary artery disease. BMC cardiovascular disorder. 2016;16:92.

    PubMed
    PubMed Center
    Article
    CASE

    Google Scholar

  • Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115:1627–35.

    CASE
    PubMed
    PubMed Center
    Article

    Google Scholar

  • Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS, et al. Obesity is a condition resistant to fibroblast growth factor 21 (FGF21). Diabetes. 2010;59:2781–9.

    CASE
    PubMed
    PubMed Center
    Article

    Google Scholar

  • Dupont M, Wu Y, Hazen SL, Tang WH. Cystatin C identifies patients with stable chronic heart failure at increased risk of adverse cardiovascular events. Cardiac failure Circ. 2012;5:602–9.

    CASE
    PubMed
    PubMed Center
    Article

    Google Scholar

  • Shulman A, Peltonen M, Sjostrom CD, Andersson-Assarsson JC, Taube M, Sjoholm K, et al. Incidence of end-stage renal disease after bariatric surgery in the Swedish study on obese subjects. Int J Obes (London). 2018;42:964–73.

    CASE
    Article

    Google Scholar

  • Rothberg AE, McEwen LN, Herman WH. Severe obesity and the impact of medical weight loss on estimated glomerular filtration rate. PLoS One. 2020;15:e0228984.

    CASE
    PubMed
    PubMed Center
    Article

    Google Scholar

  • Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W, et al. Comprehensive public health strategies to prevent the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53:522–35.

    PubMed
    Article

    Google Scholar

  • Zannad F, Ferreira JP, Pocock SJ, Zeller C, Anker SD, Butler J, et al. Cardiac and renal benefits of empagliflozin in heart failure across the spectrum of renal function: insights from EMPEROR-Reduced. Traffic. 2021;143:310–21.

    CASE
    PubMed
    Article

    Google Scholar

  • Ingelsson E, Arnlov J, Sundstrom J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart failure. 2005;7:787–91.

    PubMed
    Article

    Google Scholar

  • Register of causes of death 2018 [Available from: http://www.socialstyrelsen.se/statistics/statisticaldatabase/help/causeofdeath].

  • Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, et al. Homogeneous 96-plex PEA immunoassay with high sensitivity, specificity and excellent scalability. PLoS One. 2014;9:e95192.

    PubMed
    PubMed Center
    Article
    CASE

    Google Scholar